USClinicalTrials.gov【Trial record】
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Oct 1, 2026
Cancer types
Prostate Cancer
Incl. castration-resistant disease. 91 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 91 of 91
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
OTHERClinicalTrials.gov【Trial record】
A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer
Phase 3RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Phase 1/2RecruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
Early Phase 1Not yet recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Not applicableRecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】
Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer
Phase 2Active, not recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
Linking In With Advice and Supports for Men Impacted by Metastatic Cancer
Not applicableActive, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitationSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
PET/CT Characterization of Treatment Resistance
Not applicableRecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
Phase 2Active, not recruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study
Not applicableRecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Phase 2/3Not yet recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Not applicableNot yet recruitingSource updated: Oct 1, 2026
OTHERClinicalTrials.gov【Trial record】
A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
Phase 3RecruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Phase 3Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Addressing Health Literacy With a Tailored Survivorship Care Plan
Not applicableRecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
Phase 1/2Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Autonomic and Renal Contributions to Hypertension With ADT
Phase 4RecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Brief Title: INTROSPECT: Intraoperative PSMA PET/CT Imaging During Radical Prostatectomy
Not applicableActive, not recruitingSource updated: Sep 30, 2026
OTHERClinicalTrials.gov【Trial record】
Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer
Not applicableRecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Evaluation of Atherosclerotic Plaques in Abdominal CT Studies
Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Improving Surgeon Performance Measures for Robot-Assisted Surgery
Enrolling by invitationSource updated: Sep 30, 2026
OTHERClinicalTrials.gov【Trial record】
REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants
Phase 1/2Not yet recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
Phase 2RecruitingSource updated: Sep 30, 2026
USOTHERClinicalTrials.gov【Trial record】
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 2RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Not applicableRecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Phase 3RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Phase 4RecruitingSource updated: Sep 29, 2026
OTHERClinicalTrials.gov【Trial record】
Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (FLASH)
Not yet recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Phase 2Active, not recruitingSource updated: Sep 29, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Phase 3Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Phase 3RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
Phase 1RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3RecruitingSource updated: Aug 14, 2026
EUClinicalTrials.gov【Trial record】
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU
Phase 4Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
Phase 1Active, not recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
Phase 2RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
Phase 3Active, not recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Not applicableRecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Phase 1/2Not yet recruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Effectiveness of Posluma PET Scan for Post-Treatment Monitoring of Prostate Cancer
Phase 2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Phase 2RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Phase 2Not yet recruitingSource updated: Aug 14, 2026
EUClinicalTrials.gov【Trial record】
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
Phase 3RecruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
LuX: Xaluritamig in Participants With Metastatic Castrate Resistant Prostate Cancer and Suboptimal Response to Lutetium 177 Vipivotide Tetraxetan
Phase 2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Phase 2Not yet recruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical Prostatectomy
Not applicableNot yet recruitingSource updated: Aug 14, 2026
EUClinicalTrials.gov【Trial record】
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy
Not applicableActive, not recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
Phase 1/2Active, not recruitingSource updated: Aug 14, 2026
OTHERClinicalTrials.gov【Trial record】
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer
Phase 1/2Not yet recruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Phase 3RecruitingSource updated: Aug 14, 2026
USClinicalTrials.gov【Trial record】
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Phase 3Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Phase 2Active, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
Phase 1RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Phase 3RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Phase 3RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Dose-Escalated Proton Radiation Therapy for High-Risk Prostate Cancer
Phase 2Active, not recruitingSource updated: Aug 13, 2026
OTHERClinicalTrials.gov【Trial record】
Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)
Not applicableRecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Fusion Guided Focal Laser Ablation of Prostate Cancer
Not applicableEnrolling by invitationSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Not applicableRecruitingSource updated: Aug 13, 2026
EUClinicalTrials.gov【Trial record】
Protons vs. Photons for High-risk Prostate Cancer
Not applicableActive, not recruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Sonablate HIFU International Registry for PC & BPH Patients
RecruitingSource updated: Aug 13, 2026
USClinicalTrials.gov【Trial record】
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Phase 1RecruitingSource updated: Aug 13, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — genitourinary cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026